MAPK1 and cancer: Two recent studies showed that targeting RAF/MEK/ERK signaling together with autophagy signaling led to synthetic lethality and achieved a promising efficacy on Ras-driven cancers [298,299], suggesting that synthetic lethal factors/networks may be highly valuable for developing new drugs/methods against Ras-mutated cancers.